Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | GPR52 | Q9Y2T5 | 11/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6819904 | 1.00 | TRPV1 (0.46) | TRPV1GPR52MAPTPOLBRXFP1 | |
| SCHEMBL6425129 | 0.96 | TRPV1 (0.51) | TRPV1GPR52MAPTPOLBRXFP1 | |
| SCHEMBL6425130 | 0.96 | TRPV1 (0.51) | TRPV1GPR52MAPTPOLBRXFP1 | |
| SCHEMBL6824556 | 0.91 | GPR52 (0.55) | GPR52 | |
| SCHEMBL6824553 | 0.91 | GPR52 (0.55) | GPR52 | |
| SCHEMBL10037558 | 0.83 | GPR52 (0.50) | TRPV1GPR52MAPTHDAC3MAPK1 | |
| SCHEMBL6820227 | 0.81 | MAOB (0.45) | — | |
| SCHEMBL6820222 | 0.81 | MAOB (0.45) | — | |
| SCHEMBL13969979 | 0.79 | MAPT (0.44) | MAPTPOLBFAAH | |
| SCHEMBL21829127 | 0.78 | TDP1 (0.54) | MAPTMAPK1SLC6A3HDAC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250332124-A1 | MITOFUSIN ACTIVATORS HAVING AN ENDOCYCLIC-BONDED CARBONYL GROUP AND METHODS FOR USE THEREOF | DORN II GERALD W (US) | 2025-10-30 | — | — | US | disclosed |
| US-12396968-B2 | Mitofusin activators having an endocyclic-bonded carbonyl group and methods for use thereof | DORN II GERALD W (US) | 2025-08-26 | — | — | US | disclosed |
| US-20250091983-A1 | CYCLOPENTANE AND CYCLOHEXANE VARIANTS OF 6-PHENYLHEXANAMIDE MITOFUSIN ACTIVATORS AND METHODS FOR USE THEREOF | MITOCHONDRIA EMOTION, INC. (US) | 2025-03-20 | — | — | US | disclosed |
| EP-4504700-A1 | MITOFUSIN ACTIVATORS HAVING AN ENDOCYCLIC-BONDED CARBONYL GROUP AND METHODS FOR USE THEREOF | Dorn II, Gerald W. (US) | 2025-02-12 | — | — | EP | disclosed |
| CN-118922407-A | Mitochondrial fusion protein activators with inner loop-bonded carbonyl groups and methods of use thereof | 杰拉尔德·W·多恩二世 | 2024-11-08 | — | — | CN | disclosed |
| US-20240199534-A1 | CYCLOPROPANE ANALOGUES OF N-(TRANS-4-HYDROXYCYCLOHEXYL)-6-PHENYLHEXANAMIDE AND RELATED COMPOUNDS | DORN, GERALD W., II, DR. | 2024-06-20 | — | — | US | disclosed |
| US-20240050386-A1 | MITOFUSIN ACTIVATORS HAVING AN ENDOCYCLIC-BONDED CARBONYL GROUP AND METHODS FOR USE THEREOF | DORN II GERALD W (US) | 2024-02-15 | — | — | US | disclosed |
| EP-4308540-A1 | CYCLOPROPANE ANALOGUES OF N-(TRANS-4-HYDROXYCYCLOHEXYL)-6-PHENYLHEXANAMIDE AND RELATED COMPOUNDS | Mitochondria Emotion, Inc. (US) | 2024-01-24 | — | — | EP | disclosed |
| CN-117377652-A | Cyclopropane analogues of N- (trans-4-hydroxycyclohexyl) -6-phenylhexanamide and related compounds | 线粒体情感状态公司 | 2024-01-09 | — | — | CN | disclosed |
| WO-2023196340-A1 | MITOFUSIN ACTIVATORS HAVING AN ENDOCYCLIC-BONDED CARBONYL GROUP AND METHODS FOR USE THEREOF | DORN II GERALD W (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023014828-A2 | CYCLOPENTANE AND CYCLOHEXANE VARIANTS OF 6-PHENYLHEXANAMIDE MITOFUSIN ACTIVATORS AND METHODS FOR USE THEREOF | MITOCHONDRIA EMOTION, INC. (US) | 2023-02-09 | — | — | WO | disclosed |
| WO-2022198139-A1 | CYCLOPROPANE ANALOGUES OF N-(TRANS-4-HYDROXYCYCLOHEXYL)-6-PHENYLHEXANAMIDE AND RELATED COMPOUNDS | MITOCHONDRIA EMOTION, INC. (US) | 2022-09-22 | — | — | WO | disclosed |
| EP-0871439-B1 | SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS | AVENTIS PHARMA INC (US) | 2004-03-31 | — | — | EP | disclosed |
| US-6057369-A | USE IN THE TREATMENT OF DISEASE STATES ASSOCIATED WITH PROTEINS THAT MEDIATE CELLULAR ACTIVITY WHICH ARE CAPABLE OF BEING MODULATED BY INHIBITING A MATRIX METALLOPROTEINASE (MMP), TUMOR NECROSIS FACTOR (TNF) OR CYCLIC AMP | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 2000-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12396968-B2 | Mitofusin activators having an endocyclic-bonded carbonyl group and methods for use thereof | MFN2, CYCS, CYC1 | TRPV1 4614/4885GPR52 842/4885MAPT 3784/4885 |
| US-20240199534-A1 | CYCLOPROPANE ANALOGUES OF N-(TRANS-4-HYDROXYCYCLOHEXYL)-6-PHENYLHEXANAMIDE AND RELATED COMPOUNDS | HAGH, HADHA, NLN | TRPV1 1591/4885GPR52 3231/4885MAPT 1066/4885 |
| US-20240050386-A1 | MITOFUSIN ACTIVATORS HAVING AN ENDOCYCLIC-BONDED CARBONYL GROUP AND METHODS FOR USE THEREOF | MFN2, CYCS, CYC1 | TRPV1 4614/4885GPR52 842/4885MAPT 3784/4885 |
| US-20250091983-A1 | CYCLOPENTANE AND CYCLOHEXANE VARIANTS OF 6-PHENYLHEXANAMIDE MITOFUSIN ACTIVATORS AND METHODS FOR USE THEREOF | COQ8A, PDF, HAGH | TRPV1 3274/4885GPR52 3036/4885MAPT 1541/4885 |
| US-20250332124-A1 | MITOFUSIN ACTIVATORS HAVING AN ENDOCYCLIC-BONDED CARBONYL GROUP AND METHODS FOR USE THEREOF | MFN2, CYCS, CYC1 | TRPV1 4616/4885GPR52 855/4885MAPT 3745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.